XML 39 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Shareholders’ Deficiency (Details) - Schedule of outstanding options granted to consultants
6 Months Ended
Jun. 30, 2021
$ / shares
shares
Shareholders’ Deficiency (Details) - Schedule of outstanding options granted to consultants [Line Items]  
Options outstanding 439,201
Options exercisable 287,981
October 2013 [Member]  
Shareholders’ Deficiency (Details) - Schedule of outstanding options granted to consultants [Line Items]  
Options outstanding 5,719
Exercise price per share (in Dollars per share) | $ / shares $ 5.07
Options exercisable 5,719
Exercisable October 2023
September 2014 [Member]  
Shareholders’ Deficiency (Details) - Schedule of outstanding options granted to consultants [Line Items]  
Options outstanding 5,719
Exercise price per share (in Dollars per share) | $ / shares $ 5.07
Options exercisable 5,719
Exercisable September 2024
April 2016 [Member]  
Shareholders’ Deficiency (Details) - Schedule of outstanding options granted to consultants [Line Items]  
Options outstanding 5,975
Exercise price per share (in Dollars per share) | $ / shares $ 3.10
Options exercisable 5,975
Exercisable April 2026
December 2016 [Member]  
Shareholders’ Deficiency (Details) - Schedule of outstanding options granted to consultants [Line Items]  
Options outstanding 7,170
Exercise price per share (in Dollars per share) | $ / shares $ 3.93
Options exercisable 7,170
Exercisable December 2026
June 2017 [Member]  
Shareholders’ Deficiency (Details) - Schedule of outstanding options granted to consultants [Line Items]  
Options outstanding 197,722
Exercise price per share (in Dollars per share) | $ / shares $ 4.10
Options exercisable 156,970
Exercisable June 2027
November 2017 [Member]  
Shareholders’ Deficiency (Details) - Schedule of outstanding options granted to consultants [Line Items]  
Options outstanding 17,925
Exercise price per share (in Dollars per share) | $ / shares $ 7.70
Options exercisable 17,925
Exercisable November 2027
August 2019 [Member]  
Shareholders’ Deficiency (Details) - Schedule of outstanding options granted to consultants [Line Items]  
Options outstanding 71,700
Exercise price per share (in Dollars per share) | $ / shares $ 8.18
Options exercisable 67,197
Exercisable August 2029
June 2020 [Member]  
Shareholders’ Deficiency (Details) - Schedule of outstanding options granted to consultants [Line Items]  
Options outstanding 64,530
Exercise price per share (in Dollars per share) | $ / shares
Options exercisable 21,306
Exercisable June 2030
April 2021 [Member]  
Shareholders’ Deficiency (Details) - Schedule of outstanding options granted to consultants [Line Items]  
Options outstanding 62,741
Exercise price per share (in Dollars per share) | $ / shares $ 9.57
Options exercisable
Exercisable April 2031
Minimum [Member] | June 2020 [Member]  
Shareholders’ Deficiency (Details) - Schedule of outstanding options granted to consultants [Line Items]  
Exercise price per share (in Dollars per share) | $ / shares $ 6.62
Maximum [Member] | June 2020 [Member]  
Shareholders’ Deficiency (Details) - Schedule of outstanding options granted to consultants [Line Items]  
Exercise price per share (in Dollars per share) | $ / shares $ 6.80